20 Participants Needed

OMM for Parkinson's Disease

SY
Overseen BySheldon Yao, DO
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: New York Institute of Technology
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of the study is to investigate the effects that Osteopathic Manipulative Medicine has on lower extremity muscle characteristics in PD. Muscle stiffness, range of motion, and gait will be measured.Participants will be asked to attend one in person session at the NYIT Academic Health Care Center. Participants will be randomly assigned to a control or experimental group. After a visit with the treating physician, both groups will have muscle stiffness tested using a myotonometry meter via a MyotonPRO device, gait measured while walking on a treadmill for 2 minutes before and after treatment, and range of motion tested using a goniometer. One week after the visit, participants will be asked to complete a brief survey over the phone with one of the study investigators.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on physical assessments and treatments, so you may not need to change your medication routine.

Is Osteopathic Manipulative Medicine (OMM) safe for humans?

Osteopathic Manipulative Medicine (OMM) is generally considered safe for humans, as it is a hands-on therapy used to treat various conditions, including neurological disorders like Parkinson's disease. While there are still questions about its effectiveness, it is suggested as a safe complementary treatment to promote physical wellness.12345

How is Osteopathic Manipulative Medicine (OMM) different from other treatments for Parkinson's disease?

Osteopathic Manipulative Medicine (OMM) is a hands-on treatment that focuses on improving body function and balance by addressing somatic dysfunctions (issues with muscles and tissues). Unlike standard drug treatments for Parkinson's disease, which often focus on managing symptoms through medication, OMM uses manual techniques to enhance physical wellness and improve movement, such as gait and balance, in patients.12346

What data supports the effectiveness of the treatment Osteopathic Manipulative Medicine (OMM) for Parkinson's Disease?

Research indicates that Osteopathic Manipulative Medicine (OMM) can improve balance and gait (the way someone walks) in people with Parkinson's Disease, suggesting it may help manage movement difficulties associated with the condition.12346

Are You a Good Fit for This Trial?

This trial is for Parkinson's disease patients who can walk and have leg pain or gait issues because of their condition. They should be at a moderate stage (2-4 on the H-Y Scale) and able to lie down for tests. People with severe muscle twitching, non-PD related walking problems, or other neurological conditions like stroke or MS cannot join.

Inclusion Criteria

I can receive oral medication.
I can lie on my back and stomach comfortably.
I can walk on my own for tests.
See 2 more

Exclusion Criteria

My walking difficulties are not caused by Parkinson's disease.
I have severe muscle twitches that affect tests.
I do not have neurological conditions like stroke or multiple sclerosis.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive either Osteopathic Manipulative Treatment (OMT) or a sham control procedure to the lower extremities, with assessments of muscle stiffness, range of motion, and gait.

1 day
1 visit (in-person)

Follow-up

Participants complete a brief survey over the phone to assess outcomes one week after the treatment session.

1 week
1 visit (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Osteopathic Manipulative Medicine
  • Sham- Light touch, not reaching restrictive barrier
Trial Overview The study compares Osteopathic Manipulative Medicine (OMM), which involves hands-on techniques to improve muscle function, against a sham treatment that mimics OMM without active intervention. Muscle stiffness, walking ability, and joint movement are measured before and after sessions.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Interventional Group- OMM- Muscle energyExperimental Treatment1 Intervention
Group II: Control Group- Sham- Light touch, not reaching restrictive barrierPlacebo Group1 Intervention

Osteopathic Manipulative Medicine is already approved in United States for the following indications:

🇺🇸
Approved in United States as Osteopathic Manipulative Medicine for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

New York Institute of Technology

Lead Sponsor

Trials
56
Recruited
2,300+

Published Research Related to This Trial

In a randomized controlled trial involving 11 participants with Parkinson's disease, bi-weekly Osteopathic Manipulative Medicine (OMM) treatments for 6 weeks led to significant improvements in motor function as measured by the MDS-UPDRS scale.
While there were no significant changes in balance as assessed by the Mini-BESTest and Sensory Organization Test, the study suggests that OMM may still be a useful complementary therapy for enhancing motor function in individuals with Parkinson's disease.
Osteopathic manipulation as a complementary approach to Parkinson's disease: A controlled pilot study.DiFrancisco-Donoghue, J., Apoznanski, T., de Vries, K., et al.[2018]
Osteopathic manipulative treatment (OMT) has shown significant efficacy in managing motor-related and neurological symptoms in patients with Parkinson's disease, which is crucial for maintaining their quality of life.
Despite the promising results, research on OMT for Parkinson's disease is still limited, highlighting the need for further studies to explore its full potential and effectiveness.
Efficacy of osteopathic manipulative treatment in patients with Parkinson's disease: a narrative review.Li, R., Jose, A., Poon, J., et al.[2022]
A single session of osteopathic manipulative treatment (OMT) significantly improved gait parameters such as stride length, cadence, and maximum velocities in 10 patients with Parkinson's disease, indicating its potential efficacy in managing motor deficits.
In contrast, the sham-control group showed no significant changes, highlighting that the improvements in the treated group were likely due to the OMT rather than placebo effects.
Standard osteopathic manipulative treatment acutely improves gait performance in patients with Parkinson's disease.Wells, MR., Giantinoto, S., D'Agate, D., et al.[2019]

Citations

Osteopathic manipulation as a complementary approach to Parkinson's disease: A controlled pilot study. [2018]
Efficacy of osteopathic manipulative treatment in patients with Parkinson's disease: a narrative review. [2022]
Standard osteopathic manipulative treatment acutely improves gait performance in patients with Parkinson's disease. [2019]
A retrospective study of cranial strain patterns in patients with idiopathic Parkinson's disease. [2013]
Back to the Future: An Appraisal of the Role of Osteopathic Manipulative Treatment in Patients with Neurological Diseases. [2023]
Use of complementary therapies and non-prescribed medication in patients with Parkinson's disease. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security